Changes related to "Fludarabine (Fludara)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 02:24, 21 June 2018
   
Page name:

20 June 2018

 m   11:57  Mantle cell lymphoma‎ (diff | hist) . . (+105). . Jwarner (talk | contribs)
 m   11:53  Waldenström macroglobulinemia‎ (diff | hist) . . (+102). . Jwarner (talk | contribs)
 m   11:50  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+32). . Jwarner (talk | contribs) (Chemoradiotherapy ("Course III"))
 m   11:49  Acute myeloid leukemia‎ (diff | hist) . . (+118). . Jwarner (talk | contribs)
 m   10:38  Follicular lymphoma‎ (diff | hist) . . (-3,669). . Jwarner (talk | contribs)

19 June 2018

 m   22:51  Waldenström macroglobulinemia‎ (diff | hist) . . (+43). . Jwarner (talk | contribs)
 m   22:49  Marginal zone lymphoma‎ (diff | hist) . . (+57). . Jwarner (talk | contribs) (Fludarabine & Rituximab {{#subobject:413f96|Regimen=1}})
 m   22:46  Follicular lymphoma‎‎ (2 changes | history) . . (+42). . [Jwarner‎ (2×)]
 m    22:46 (cur | prev) . . (-16). . Jwarner (talk | contribs)
 m    22:45 (cur | prev) . . (+58). . Jwarner (talk | contribs) (Advanced disease, first-line therapy, non-randomized or retrospective data)
 m   22:42  Cold agglutinin disease‎ (diff | hist) . . (+119). . Jwarner (talk | contribs) (Fludarabine & Rituximab {{#subobject:96c221|Regimen=1}})
 m   17:49  Chronic lymphocytic leukemia (CLL/SLL)‎ (diff | hist) . . (+11). . Jwarner (talk | contribs)
 m   17:12  Acute myeloid leukemia‎‎ (2 changes | history) . . (+211). . [Jwarner‎ (2×)]
 m    17:12 (cur | prev) . . (+207). . Jwarner (talk | contribs) (F-SHAI {{#subobject:9e1c5f|Regimen=1}})
 m    17:08 (cur | prev) . . (+4). . Jwarner (talk | contribs) (SHAI {{#subobject:6f1931|Regimen=1}})

18 June 2018

 m   23:09  Acute myeloid leukemia‎‎ (5 changes | history) . . (+1,695). . [Jwarner‎ (5×)]
 m    23:09 (cur | prev) . . (+113). . Jwarner (talk | contribs) (Relapsed or refractory, salvage therapy)
 m    18:00 (cur | prev) . . (+11). . Jwarner (talk | contribs) (Etoposide & Mitoxantrone {{#subobject:ab1766|Regimen=1}})
 m    17:59 (cur | prev) . . (+16). . Jwarner (talk | contribs) (Busulfan & Cyclophosphamide {{#subobject:9acbe9|Regimen=1}})
 m    17:59 (cur | prev) . . (+1,483). . Jwarner (talk | contribs) (CIA {{#subobject:db5c09|Regimen=1}})
 m    13:42 (cur | prev) . . (+72). . Jwarner (talk | contribs) (ADE {{#subobject:d16134|Regimen=1}})
 m   20:56  Hodgkin lymphoma‎‎ (2 changes | history) . . (+148). . [Jwarner‎ (2×)]
 m    20:56 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Subsequent treatment)
 m    20:55 (cur | prev) . . (+144). . Jwarner (talk | contribs) (Consolidation after upfront therapy)
 m   20:48  Follicular lymphoma‎‎ (3 changes | history) . . (-2,875). . [Jwarner‎ (3×)]
 m    20:48 (cur | prev) . . (+431). . Jwarner (talk | contribs) (BVR {{#subobject:ad1aa9|Regimen=1}})
 m    20:43 (cur | prev) . . (-3,314). . Jwarner (talk | contribs) (VBR {{#subobject:bdecdf|Regimen=1}})
 m    17:48 (cur | prev) . . (+8). . Jwarner (talk | contribs)
 m   17:52  Waldenström macroglobulinemia‎ (diff | hist) . . (+81). . Jwarner (talk | contribs)
 m   17:27  Chronic lymphocytic leukemia (CLL/SLL)‎‎ (5 changes | history) . . (-3,648). . [Jwarner‎ (5×)]
 m    17:27 (cur | prev) . . (+147). . Jwarner (talk | contribs) (BendOfa {{#subobject:4eab04|Regimen=1}})
 m    17:24 (cur | prev) . . (+2,297). . Jwarner (talk | contribs) (CFAR {{#subobject:30ac6b|Regimen=1}})
 m    17:23 (cur | prev) . . (-2,273). . Jwarner (talk | contribs) (G-B {{#subobject:e26569|Regimen=1}})
 m    11:38 (cur | prev) . . (+21). . Jwarner (talk | contribs) (Placebo)
 m    11:27 (cur | prev) . . (-3,840). . Jwarner (talk | contribs) (Lenalidomide monotherapy {{#subobject:9820ba|Regimen=1}})

17 June 2018

 m   20:33  Hodgkin lymphoma‎‎ (2 changes | history) . . (+3,054). . [Jwarner‎ (2×)]
 m    20:33 (cur | prev) . . (+2,141). . Jwarner (talk | contribs) (ABVD {{#subobject:8b9772|Regimen=1}})
 m    20:19 (cur | prev) . . (+913). . Jwarner (talk | contribs) (Escalated BEACOPP {{#subobject:ca99d7|Regimen=1}})

16 June 2018

 m   16:51  Acute myeloid leukemia‎ (diff | hist) . . (+3,472). . Jwarner (talk | contribs)

13 June 2018

 m   22:12  Chronic lymphocytic leukemia (CLL/SLL)‎ (diff | hist) . . (+31). . Warner-admin (talk | contribs) (Text replacement - "*Total body irradiation" to "*Total body irradiation")
 m   22:10  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+35). . Warner-admin (talk | contribs) (Text replacement - "*Cranial irradiation" to "*Whole-brain irradiation")
 m   21:58  Hodgkin lymphoma‎ (diff | hist) . . (+496). . Warner-admin (talk | contribs)
 m   21:51  Peripheral T-cell lymphoma‎ (diff | hist) . . (+31). . Warner-admin (talk | contribs) (Radiotherapy)